AvalonBay Communities, Inc., a member of the S&P 500, is an equity REIT that develops, redevelops, acquires and manages apartment communities in leading metropolitan areas in New England, the New York/New Jersey Metro area, the Mid-Atlantic, the Pacific Northwest, and Northern and Southern California, as well as in the Company's expansion regions of Raleigh-Durham and Charlotte, North Carolina, Southeast Florida, Dallas and Austin, Texas, and Denver, Colorado. As of December 31, 2024, the Company owned or held a direct or indirect ownership interest in 306 apartment communities containing 93,518 apartment homes in 12 states and the District of Columbia, of which 17 communities were under development.

AvalonBay Communities Inc.

Analysts have been eager to weigh in on the Healthcare sector with new ratings on ArriVent BioPharma, Inc. (AVBP) and Oncolytics Biotech (ONCY). Ar...

Analysts Have Conflicting Sentiments on These Healthcare Companies: ArriVent BioPharma, Inc. (AVBP) and Oncolytics Biotech (ONCY)

In a report released today, Soumit Roy from JonesTrading maintained a Buy rating on ArriVent BioPharma, Inc., with a price target of $45.00. Accord...

JonesTrading Remains a Buy on ArriVent BioPharma, Inc. (AVBP)

Avidbank Holdings ( ($AVBH) ) has issued an announcement. On March 9, 2026, Avidbank Holdings, Inc. appointed veteran finance executive Keith F. Je...

Market Cap	$26.38B	P/E Ratio	14.91
52W High	$213.34	52W Low	$160.10
Div Yield	712.0%	Payout Ratio	347.0%
EPS Growth 3Y	1.9%	52W Position	15.8%
Overall Score	62	Value Score	100
Quality Score	60	Technical Score	27

EPS Current Est	$11.3	EPS Next Est	$11.72
EPS Growth Est	+3.7%	DPS Growth 3Y	2.3%

	A	B	C	D
1	Symbol	Price	Change	Volume
2	AVB	$168.51	0.00%	915.07K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	AVB	$168.51	0%	915.07K
3
4
5
6

AVB

AVB

Key Metrics Overview

Growth Analysis

Revenue (5Y)

EBITDA (5Y)

Get AvalonBay Communities Inc. Data in Excel

Get AvalonBay Communities Inc. Data in Excel